🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.

“The shining star of our household has faded away for us in the present world,” his relatives stated. “After a lengthy and brave battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and partnerships with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his music career into the limelight. The album premiered at the top spot on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal showed the artist, famously stripped down to his midsection, performing directly into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a serious vehicle accident that left him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the R&B chart and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo made only a few public appearances in the following years.

The musician was scheduled as a headliner for the 2025 music event, but his appearance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s health in the weeks leading up to his passing, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent forms of the illness, on a gifted artist whose existence was cut short.

“We are grieved that he can only leave dear memories with his family, but we are eternally grateful for the heritage of deeply emotional songs he leaves behind,” his family said.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic malignancy impacts the digestive organ, a small organ that produces the hormone insulin and is vital in digestion, among other functions. The position and dimensions of the pancreas in the body make it more difficult to detect cancer.

Even though this cancer accounts for only about 3% of malignancy cases annually in the United States, it is responsible for 7% of cancer deaths.

Almost seventy thousand people will be diagnosed with pancreatic cancer and roughly 52,000 will succumb to the disease in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and ineffective treatment options, and a narrow opportunity to make a significant difference on the lives of patients,” said a cancer specialist.

Since this disease rarely causes early symptoms, it’s frequently diagnosed only once the disease is advanced. Even when a individual has symptoms they are usually vague and may be confused with a number of common illnesses.

“Currently, there is no good way to detect this malignancy in the early stages, apart from paying attention to physical changes and speaking with your physician if there are unfamiliar signs,” explained a health expert.

Frequent indicators of pancreatic cancer encompass:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an outlier, as this malignancy is most common in individuals in the 65 to 75 range. However, many cancers, including pancreatic cancer, have become more common among younger adults.

“This disease identified before the age of 50 is deemed rare, yet alarmingly, doctors are noticing a rising count of younger patients suffering from this disease,” said a expert.

Genetic Background Impacts Cancer Risk

In the absence of effective detection methods for this malignancy, professionals stressed the significance of knowing your family’s cancer history. Certain contributing elements, such as tobacco use and obesity also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of pancreatic cancer in the United States and are most likely to be found to have inoperable cancer.

“The initial action toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. Individuals should review their genetic background, hereditary factors, and medical conditions, such as diabetes, long-term pancreas inflammation, or obesity that may raise their vulnerability,” advised a medical professional.

Inherited genetic risk factors are linked to as much as ten percent of all pancreatic cancer cases. If a relative in your household has had pancreatic cancer, you may want to consider genetic testing.

“For individuals with a family history of pancreatic cancer or those having elevated risk genetic mutations, checking may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the pancreas,” he explained.

For those looking to reduce their risk, habit adjustments may have an effect. The best step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so limiting or avoiding drinks may help reduce your risk.

Managing your body mass or shedding pounds may also help reduce your risk. Individuals with excess weight are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in people with diabetes, and reducing weight can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are developing targeted therapies that are already showing results,” said a specialist.

For many individuals, however, education about this rare but {dev